Funded Biotechnology Startups in Dallas
Biotechnology funding in Dallas shows a pronounced size outlier at the top of the list: Taysha Gene Therapies closed a $200M round on 2026-06-24, which dwa…
Biotechnology funding in Dallas shows a pronounced size outlier at the top of the list: Taysha Gene Therapies closed a $200M round on 2026-06-24, which dwarfs the next-largest disclosed amount ($60M by Colossal Biosciences on 2026-02-03). After that, disclosed rounds cluster mostly in mid-to-lower ranges, including $30M (Secretome Therapeutics, 2026-05-27) and $15M (ReCode Therapeutics, 2024-11-18), with one low end concentrated in small disclosed rounds such as ClearSight Therapeutics at $30K on 2024-09-06.
Most entries also sit in a tight local geography: all 11 rows list Dallas, Texas. Temporally, the displayed set spans 2020-08-03 (Instil Bio) to 2026-06-24 (Taysha Gene Therapies), with several of the largest disclosed rounds landing between 2026-05-08 and 2026-06-24. Stage labels are mixed, but “Series Unknown” appears repeatedly (5 of 11 rows), while the smallest disclosed amount is $30K for ClearSight Therapeutics (2024-09-06).
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest recent disclosed round in this Dallas biotechnology list, and how far above the rest is it?
Taysha Gene Therapies’ $200M round on 2026-06-24 is the clear outlier in this dataset, with the next-largest disclosed amount coming from Colossal Biosciences at $60M on 2026-02-03.
Do most rounds cluster around a particular time window in the most recent entries?
Yes. Several large and mid-size disclosed rounds fall within a short 2026 window—e.g., Secretome Therapeutics ($30M, 2026-05-27), Vivakor ($12M, 2026-05-08), and Taysha Gene Therapies ($200M, 2026-06-24).
How concentrated is the geography—are there multiple cities, or is Dallas consistently represented?
Geography is highly concentrated: all 11 entries list Dallas, Texas, with no other city shown across the rows.
What stage/label pattern dominates this list, based on how often “Series Unknown” appears?
“Series Unknown” appears in 5 of 11 rows, including Taysha Gene Therapies (2026-06-24), EtiraRx (2026-05-13), Vivakor (2026-05-08), ImmuneSensor Therapeutics (2022-12-05), and Dose Therapeutics (2022-05-11).
Are there unusually small disclosed rounds that stand out from the rest?
ClearSight Therapeutics is the low-end outlier with a $30K disclosed amount on 2024-09-06, far below other disclosed figures such as Vaxxinity’s $9M (2022-04-07) and Dose Therapeutics’ $10M (2022-05-11).
Which biotech companies in this list appear to have the most recent round dates, and what are the amounts?
The most recent round date shown is 2026-06-24 for Taysha Gene Therapies at $200M. The next-most-recent dates are 2026-05-27 (Secretome Therapeutics, $30M) and 2026-05-13 (EtiraRx, $2M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.